Related Experiment Video
Updated: Nov 28, 2025

10:55
Detection of Anti-MDA5 Autoantibodies Using HeLa Cells and Immunocytochemistry with Light Microscopy
Published on: October 31, 2025
421
Amyopathic dermatomyositis combined with peripheral neuropathy
Zenshi Miyake1, Akiko Ishii2, Naoko Okiyama3
1Neurology, University of Tsukuba Hospital, Tsukuba, Ibaraki, Japan.
BMJ Case Reports
|December 1, 2020
Summary
This report details the first case of amyopathic dermatomyositis with peripheral neuropathy. The findings support the concept of neuromyositis, linking autoimmune muscle and nerve conditions.
Area of Science:
- Neurology
- Dermatology
- Immunology
Background:
- Amyopathic dermatomyositis (ADM) is an idiopathic inflammatory myopathy characterized by skin manifestations without significant muscle enzyme elevation or weakness.
- Peripheral neuropathy involves damage to the peripheral nerves, leading to sensory and motor deficits.
- The co-occurrence of these conditions is rare and poorly understood.
Observation:
- A 49-year-old woman presented with leg muscle weakness and paresthesias.
- Nerve conduction studies and antiganglioside antibodies confirmed autoimmune peripheral neuropathy.
- Skin lesions, interstitial pneumonia, and anti-MDA5 antibodies led to an ADM diagnosis.
Findings:
- This case represents the first documented instance of amyopathic dermatomyositis concurrently diagnosed with peripheral neuropathy.
- The patient exhibited characteristic skin findings and interstitial lung disease associated with anti-melanoma differentiation-associated protein 5 (anti-MDA5) antibodies.
- Neuropathy was confirmed through electrodiagnostic studies and serological markers.
Implications:
- This case provides crucial evidence for the existence of neuromyositis, a condition merging inflammatory myopathy and neuropathy.
- It highlights the importance of considering peripheral neuropathy in patients with ADM, especially those with anti-MDA5 antibodies.
- Further research into the shared immunological pathways of ADM and peripheral neuropathy is warranted.
More Related Videos
Related Concept Videos
Myasthenia Gravis: Overview and Treatment
2.4K
Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
2.4K
Myasthenia Gravis: Diagnostic Tests
1.7K
Myasthenia gravis is an autoimmune condition affecting neuromuscular transmission, causing generalized weakness in skeletal muscles. Initial diagnoses rely on patients' signs, symptoms, and medical history. The challenge lies in distinguishing myasthenia from other muscular dystrophies. An important diagnostic feature is the significant improvement of symptoms after administering anticholinesterase inhibitors.
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
1.7K
Disorders of the Skeletal Muscle
1.5K
The clinical conditions affecting the skeletal muscle tissue are broadly categorized as musculoskeletal and neuromuscular disorders.
Musculoskeletal disorders
Musculoskeletal disorders involve injuries and conditions affecting the skeletal muscles and associated connective tissues. These disorders can arise from acute biomechanical stresses or chronic overuse and can occur across different age groups. Common injuries include sprains, fractures, and muscular strains, often resulting from...
Musculoskeletal disorders
Musculoskeletal disorders involve injuries and conditions affecting the skeletal muscles and associated connective tissues. These disorders can arise from acute biomechanical stresses or chronic overuse and can occur across different age groups. Common injuries include sprains, fractures, and muscular strains, often resulting from...
1.5K
Chemical Synapses
10.7K
Chemical synapses are specialized sites between two neurons or between a neuron and a non-neuronal cell like a muscle, glandular or sensory cell.
Because chemical synapses depend on the release of neurotransmitter molecules from synaptic vesicles to pass on their signal, there is an approximately one millisecond delay between when the axon potential reaches the presynaptic terminal and when the neurotransmitter leads to opening of postsynaptic ion channels. Additionally, this signaling is...
Because chemical synapses depend on the release of neurotransmitter molecules from synaptic vesicles to pass on their signal, there is an approximately one millisecond delay between when the axon potential reaches the presynaptic terminal and when the neurotransmitter leads to opening of postsynaptic ion channels. Additionally, this signaling is...
10.7K
Chemical Synapses
3.8K
Chemical synapses are specialized sites between two neurons or between a neuron and a non-neuronal cell like a muscle, glandular or sensory cell.
Because chemical synapses depend on the release of neurotransmitter molecules from synaptic vesicles to pass on their signal, there is an approximately one millisecond delay between when the axon potential reaches the presynaptic terminal and when the neurotransmitter leads to opening of postsynaptic ion channels. Additionally, this signaling is...
Because chemical synapses depend on the release of neurotransmitter molecules from synaptic vesicles to pass on their signal, there is an approximately one millisecond delay between when the axon potential reaches the presynaptic terminal and when the neurotransmitter leads to opening of postsynaptic ion channels. Additionally, this signaling is...
3.8K
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation
179
Clinical manifestationsPeripheral Arterial Disease (PAD) manifests through a range of symptoms, from the characteristic intermittent claudication to atypical presentations and severe complications in advanced stages. Intermittent claudication, a hallmark symptom of PAD, presents as exercise-induced muscle pain that typically resolves within minutes of rest. This pain is reproducible and stems from inadequate blood flow, leading to the accumulation of lactic acid produced during anaerobic...
179

